Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
The 20mg format supports longer studies, multiple experimental replicates, and reduced batch variability in advanced research projects
We recommend reviewing our FAQ section for common queries regarding minimum order quantities (MOQ)
Billing Settings Overview If your practice uses Elation Billing , fee schedules configured in Elation Billing take precedence over EHR billing settings
Its important to follow the right protocols
Heres what the clinical evidence shows: Study Scope: 900+ participants across 6 randomized, double-blind, placebo-controlled trials Safety Profile: Indistinguishable from placebo in tolerability assessments Serious Events: Zero serious adverse events attributed to AOD-9604 Withdrawals: No treatment-related discontinuations in any trial Common Effects: Mild headache and minor GI symptoms at rates similar to placebo IGF-1 Impact: No effect on insulin-like growth factor-1 levels Metabolic Safety: No negative impact on glucose metabolism or insulin sensitivity Immunogenicity: Zero participants developed anti-AOD9604 antibodies The following analysis provides complete details on the clinical trial evidence supporting AOD-9604s favorable safety profile
US$ 24.87
US$ 20.95
US$ 29.64
US$ 24.52
